Published in J Virol on June 01, 1998
Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev (2002) 2.86
Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol (2000) 1.82
Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol (2004) 1.43
Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother (2009) 1.30
Invasive extravillous trophoblasts restrict intracellular growth and spread of Listeria monocytogenes. PLoS Pathog (2011) 1.09
Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta. J Virol (2007) 1.02
Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture. J Virol (2011) 0.96
Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factor-alpha. Am J Pathol (2002) 0.92
Models of vertical cytomegalovirus (CMV) transmission and pathogenesis. Semin Immunopathol (2014) 0.84
Polarized release of human cytomegalovirus from placental trophoblasts. J Virol (2002) 0.82
Permissive human cytomegalovirus infection of a first trimester extravillous cytotrophoblast cell line. Virol J (2004) 0.81
Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection. J Virol (2003) 0.81
Horizontal in utero acquisition of cytomegalovirus infection in a twin pregnancy. J Clin Microbiol (2003) 0.79
Perivascular stromal cells as a potential reservoir of human cytomegalovirus. Am J Transplant (2014) 0.78
Cytomegalovirus and paediatric HIV infection. J Virus Erad (2016) 0.75
Placental pericytes and cytomegalovirus infectivity: Implications for HCMV placental pathology and congenital disease. Am J Reprod Immunol (2017) 0.75
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal Biochem (1979) 5.67
Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology (1986) 4.89
Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A (1984) 4.56
Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA (1986) 3.37
Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. J Virol (1977) 3.07
Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics (1980) 2.35
Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology (1993) 2.02
Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections. Pediatrics (1977) 1.66
Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J Virol (1995) 1.52
Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis (1995) 1.42
Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microb Pathog (1987) 1.39
Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol (1988) 1.30
Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro. J Cell Sci (1991) 1.29
The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol (1985) 1.20
Differentiation of human trophoblast cells in vitro as revealed by immunocytochemical staining of desmoplakin and nuclei. J Cell Sci (1990) 1.18
Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining. Virchows Arch A Pathol Anat Histopathol (1993) 1.17
ICAM-1-mediated adhesion of peripheral blood monocytes to the maternal surface of placental syncytiotrophoblasts: implications for placental villitis. Am J Pathol (1997) 1.16
Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J Clin Endocrinol Metab (1987) 1.13
Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation (1994) 1.11
Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus. Immunology (1993) 1.09
Cytomegalovirus infection of human teratocarcinoma cells in culture. J Gen Virol (1985) 1.09
Prenatal cytomegalovirus infection: epidemiology, pathology and pathogenesis. Perspect Pediatr Pathol (1981) 1.07
Improved method for immunoperoxidase detection of membrane antigens in frozen sections. J Clin Pathol (1989) 1.06
Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J Cell Physiol (1996) 1.03
Functional, long-term cultures of human term trophoblasts purified by column-elimination of CD9 expressing cells. Placenta (1994) 1.03
Subcellular localization of the major immediate early protein (IE1) of human cytomegalovirus at early times after infection. Virology (1988) 1.01
Cytomegalovirus infection of the human placenta: an immunocytochemical study. Hum Pathol (1992) 1.00
Interactions between human immunodeficiency virus type 1 and human cytomegalovirus in human term syncytiotrophoblast cells coinfected with both viruses. J Virol (1995) 0.99
The consequences of primary cytomegalovirus infection in pregnancy. Arch Dis Child (1983) 0.98
Placental and fetal manifestations of cytomegalovirus infection. Virchows Arch B Cell Pathol (1974) 0.95
Placental evidence of cytomegalovirus infection of the fetus and neonate. Arch Pathol Lab Med (1984) 0.92
Cytomegalovirus replication in primary and passaged human placental cells. Intervirology (1981) 0.89
Experimental primary cytomegalovirus infection in pregnancy: timing and fetal outcome. Am J Obstet Gynecol (1983) 0.88
Virus-specific antibody responses in mothers and their newborn infants with asymptomatic congenital cytomegalovirus infections. J Infect Dis (1993) 0.88
Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells. Am J Pathol (1996) 0.88
Human cytomegalovirus: demonstration of permissive epithelial cells and nonpermissive fibroblastic cells in a survey of human cell lines. J Virol (1986) 0.88
Antiviral antibody responses in mothers and their newborn infants with clinical and subclinical congenital cytomegalovirus infections. J Infect Dis (1990) 0.87
Placental morphology in cytomegalovirus infection. Placenta (1989) 0.87
Cytomegalic inclusion disease of a nineteen-week fetus. Case report including a study of the placenta. Am J Obstet Gynecol (1971) 0.86
Congenital cytomegalic inclusion disease. Observations in a macerated fetus with congenital defect, including a study of the placenta. Am J Obstet Gynecol (1962) 0.85
The presence of cytomegalovirus antigens in karyotyped abortions. Am J Reprod Immunol (1994) 0.85
Increased expression of adhesion molecules (CD54, CD29 and CD44) on fibroblasts infected with cytomegalovirus. Microbiol Immunol (1995) 0.85
Alteration of the growth of cytomegalovirus and herpes simplex virus type 1 by epidermal growth factor, a contaminant of crude human chorionic gonadotropin preparations. J Clin Invest (1978) 0.84
Characterization of the fetal inflammatory response to cytomegalovirus placentitis. An immunohistochemical study. Arch Pathol Lab Med (1992) 0.83
In situ hybridization analysis for cytomegalovirus in chronic villitis. Pediatr Pathol (1990) 0.83
Human cytomegalovirus infection of human placental explants in culture: histologic and immunohistochemical studies. Am J Obstet Gynecol (1987) 0.82
Kinetics of HIV infection of human placental syncytiotrophoblast cultures: an ultrastructural and immunocytochemical study. AIDS Res Hum Retroviruses (1995) 0.81
Absence of cytomegalovirus in gestational tissue in recurrent spontaneous abortion. Diagn Mol Pathol (1993) 0.81
Cytomegalovirus in the perfused human term placenta in vitro. Placenta (1995) 0.81
Viral placentitis in congenital cytomegalovirus infection. Am J Clin Pathol (1972) 0.81
Persistence of human cytomegalovirus DNA sequences without cell-virus homology in human placental explants in culture. Int J Fertil (1990) 0.81
Detection of the human cytomegalovirus gene in placental chronic villitis by polymerase chain reaction. Hum Pathol (1994) 0.80
Human cytomegalovirus infection: recent developments in diagnosis and epidemiology. Klin Wochenschr (1985) 0.80
Bidirectional enhancing activities between human T cell leukemia-lymphoma virus type I and human cytomegalovirus in human term syncytiotrophoblast cells cultured in vitro. AIDS Res Hum Retroviruses (1995) 0.78
Chronic intervillositis of the placenta. Arch Pathol Lab Med (1993) 0.77
Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell (1982) 5.19
CSF-1--a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem (1983) 3.31
Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science (1992) 2.90
Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. J Infect Dis (1982) 2.29
Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients. Am J Transplant (2009) 2.25
Specific interaction of murine colony-stimulating factor with mononuclear phagocytic cells. J Cell Biol (1980) 2.12
The association of urinary tract infection with sexual intercourse. J Infect Dis (1982) 2.05
Partial replacement of serum by selenite, transferrin, albumin and lecithin in haemopoietic cell cultures. Nature (1976) 2.02
Distribution of cells bearing receptors for a colony-stimulating factor (CSF-1) in murine tissues. J Cell Biol (1981) 1.99
Complete replacement of serum in primary cultures of erythropoietin-dependent red cell precursors (CFU-E) by albumin, transferrin, iron, unsaturated fatty acid, lecithin and cholesterol. Exp Cell Res (1980) 1.98
The interaction of 125I-colony-stimulating factor-1 with bone marrow-derived macrophages. J Biol Chem (1986) 1.92
Molecules stimulating early red cell, granulocyte, macrophage, and megakaryocyte precursors in culture: similarity in size, hydrophobicity, and charge. J Cell Physiol Suppl (1982) 1.77
Human colony-stimulating factor (CSF-1) radioimmunoassay: resolution of three subclasses of human colony-stimulating factors. Blood (1981) 1.67
Methods for the purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1). J Immunol Methods (1981) 1.60
Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol (1996) 1.60
Composition and functional integrity of the in vitro hemopoietic microenvironment in acute myelogenous leukemia: effect of macrophage colony-stimulating factor. Exp Hematol (1992) 1.40
Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta (1994) 1.34
Cytoadherence of Plasmodium falciparum to intercellular adhesion molecule 1 and chondroitin-4-sulfate expressed by the syncytiotrophoblast in the human placenta. Infect Immun (1997) 1.28
Discrimination of a colony stimulating factor subclass by a specific receptor on a macrophage cell line. J Cell Physiol (1980) 1.16
ICAM-1-mediated adhesion of peripheral blood monocytes to the maternal surface of placental syncytiotrophoblasts: implications for placental villitis. Am J Pathol (1997) 1.16
Changes in BMI over 6 years: the role of demographic and neighborhood characteristics. Int J Obes (Lond) (2010) 1.16
Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat (2010) 1.13
The role of cytokines in gestation. Crit Rev Immunol (1994) 1.09
Biology of the hemopoietic microenvironment. Eur J Haematol (1992) 1.08
Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium). J Pharm Pharmacol (2001) 1.05
Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report. Am J Transplant (2010) 1.05
A specific and reliable bioassay for the detection of femtomolar levels of human and murine tumor necrosis factors. J Immunol Methods (1991) 1.04
Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J Cell Physiol (1996) 1.03
Functional, long-term cultures of human term trophoblasts purified by column-elimination of CD9 expressing cells. Placenta (1994) 1.03
Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy (2001) 1.03
Monocytes adhering by LFA-1 to placental syncytiotrophoblasts induce local apoptosis via release of TNF-alpha. A model for hematogenous initiation of placental inflammations. J Leukoc Biol (2000) 1.00
Modulation of receptors for the colony-stimulating factor, CSF-1, by bacterial lipopolysaccharide and CSF-1. J Immunol Methods (1984) 1.00
Production of colony-stimulating factor-1 (CSF-1) by mouse astroglia in vitro. J Neurosci Res (1990) 0.98
Epstein-barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients. Am J Transplant (2009) 0.98
Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts. Biol Reprod (2000) 0.95
Demonstration of functional cytokine-placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion. Exp Cell Res (1994) 0.94
Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant (2007) 0.93
Synergistic stimulation of macrophage proliferation by the monokines tumor necrosis factor-alpha and colony-stimulating factor 1. Blood (1989) 0.92
Multiple anti-apoptotic pathways stimulated by EGF in cytotrophoblasts. Placenta (2005) 0.92
Effect of oxygen levels in villous trophoblast apoptosis. Placenta (2003) 0.92
Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts. J Cell Physiol (1999) 0.91
Expression of the human p55 and p75 tumor necrosis factor receptors in primary villous trophoblasts and their role in cytotoxic signal transduction. Biol Reprod (1996) 0.90
Villous trophoblasts cultured on semi-permeable membranes form an effective barrier to the passage of high and low molecular weight particles. Placenta (2001) 0.90
Immune signalling at the maternal-fetal interface and trophoblast differentiation. Dev Comp Immunol (1993) 0.90
Tumor necrosis factor production is deficient in diabetes-prone BB rats and can be corrected by complete Freund's adjuvant: a possible immunoregulatory role of tumor necrosis factor in the prevention of diabetes. Clin Immunol Immunopathol (1992) 0.89
In vitro differentiation of villous trophoblasts from pregnancies complicated by intrauterine growth restriction with and without pre-eclampsia. Placenta (2007) 0.89
Ultraviolet-inactivated human cytomegalovirus induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and tumour necrosis factor-alpha dependent manner. J Pathol (2006) 0.89
Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder. Am J Transplant (2012) 0.87
Hantavirus pulmonary syndrome in northern Alberta, Canada: clinical and laboratory findings for 19 cases. Clin Infect Dis (2000) 0.87
Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis. Can J Infect Dis (2001) 0.84
Carbonic anhydrase catalyzed hydrolysis and decarboxylation. Kinetic studies of enzyme-catalyzed decomposition of mono- and disubstituted derivatives of carbonic acid. Biochemistry (1974) 0.84
High levels of Epstein-Barr virus in the oropharynx: a predictor of disease progression in human immunodeficiency virus infection. J Med Virol (1990) 0.84
The effect of oxygen tension on intracellular survival signalling in primary villous trophoblasts. Placenta (2003) 0.84
Differentiation of subsets of CD4+ and CD8+ T cells. Ciba Found Symp (1995) 0.83
Endogenous tumor necrosis factor alpha mediates enhanced apoptosis of cultured villous trophoblasts from intrauterine growth-restricted placentae. Reproduction (2007) 0.83
Human cytomegalovirus-induced upregulation of intercellular cell adhesion molecule-1 on villous syncytiotrophoblasts. Biol Reprod (2004) 0.83
Death receptor Fas/Apo-1/CD95 expressed by human placental cytotrophoblasts does not mediate apoptosis. Biol Reprod (1999) 0.83
Antimicrobial prophylaxis for open heart operations. Ann Thorac Surg (1990) 0.83
Polarized release of human cytomegalovirus from placental trophoblasts. J Virol (2002) 0.82
The nature of 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated hemopoiesis, colony stimulating factor (CSF) requirement for colony formation, and the effect of TPA on [125I]CSF-1 binding to macrophages. J Cell Physiol (1983) 0.82
Human cytomegalovirus interacts with toll-like receptor 2 and CD14 on syncytiotrophoblasts to stimulate expression of TNFalpha mRNA and apoptosis. Placenta (2009) 0.82
Characterization of cytokine production by the metrial gland and granulated metrial gland cells. J Reprod Immunol (1991) 0.82
Immune interferon induces early and late events in differentiation of HL-60 cells that are part of the same maturation program. Exp Hematol (1991) 0.81
The role of Bcl-2 expression in EGF inhibition of TNF-alpha/IFN-gamma-induced villous trophoblast apoptosis. Placenta (1999) 0.81
Nitric oxide generation affects pro- and anti-angiogenic growth factor expression in primary human trophoblast. Placenta (2011) 0.80
A porcine trophoblast cell line that secretes growth factors which stimulate porcine macrophages. Biol Reprod (1993) 0.80
Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures. Exp Hematol (1990) 0.79
The role of reactive nitrogen/oxygen intermediates in cytokine-induced trophoblast apoptosis. Placenta (1999) 0.79
The contribution of apoptosis-inducing factor (AIF) to villous trophoblast differentiation. Placenta (2011) 0.79
Identification of an erythropoietin-sensitive cell line. Blood (1987) 0.78
Differential expression of tumor necrosis factor-alpha isoforms from lipopolysaccharide- and cytokine-stimulated mouse macrophages. Int J Biochem Cell Biol (1996) 0.78
Folate affects apoptosis in human trophoblastic cells. BJOG (2000) 0.78
Prevalence and determinants of HIV-1 subtypes in Canada: enhancing routinely collected information through the Canadian HIV Strain and Drug Resistance Surveillance Program. Can Commun Dis Rep (2003) 0.78
Lack of class I major histocompatibility antigens on trophoblast of periimplantation blastocysts and term placenta in the pig. Biol Reprod (1999) 0.78
The in situ expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) mRNA at the maternal-fetal interface. Growth Factors (1991) 0.77
Autocrine regulation of macrophage proliferation by tumor necrosis factor-alpha. Exp Hematol (1996) 0.77
The expression and localization of mRNA for colony-stimulating factor (CSF)-1 in human term placenta. Hum Reprod (1992) 0.77
Catalytic versatility of erythrocyte carbonic anhydrase. Kinetic studies of the enzyme-catalyzed hydrolysis of methyl pyridyl carbonates. Biochemistry (1972) 0.76
Matrix metalloproteinase release from placental explants of pregnancies complicated by intrauterine growth restriction. J Soc Gynecol Investig (2004) 0.76
Functional characterization of fibroblastic cells in long-term marrow cultures from patients with acute myelogenous leukemia. Leukemia (1993) 0.75
Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder? Transplant Proc (1991) 0.75
Inhibition of hematopoiesis in normal human long-term marrow cultures treated with recombinant human macrophage colony-stimulating factor. Blood (1991) 0.75
Cyclosporine-associated lymphoproliferation, despite controlled cyclosporine blood concentrations, in a renal allograft recipient. Proc Eur Dial Transplant Assoc Eur Ren Assoc (1985) 0.75
The characterization of fibrocyte-like cells: a novel fibroblastic cell of the placenta. Placenta (2012) 0.75
Human cytotrophoblastic cells absorb the NK blocking activity of monoclonal BA11. Am J Reprod Immunol (1997) 0.75
CSF-1 and immune interferon synergize to induce differentiation of human leukemic cells bearing CSF-1 receptors. Leuk Res (1991) 0.75
Effect of rhCSF-1 on human hemopoiesis in long-term cultures from patients with acute myelogenous leukemia. Leukemia (1991) 0.75